treatment Archives | Be Korea-savvy
S. Korea to Conduct Tests of COVID-19 Vaccine, Treatment Candidates on Monkeys This Month

S. Korea to Conduct Tests of COVID-19 Vaccine, Treatment Candidates on Monkeys This Month

SEOUL, June 17 (Korea Bizwire) — South Korea will test treatment and vaccine candidates against the new coronavirus on monkeys this month, the science ministry said Wednesday. Two experimental treatments and one vaccine candidate against the novel coronavirus under development by unidentified firms or research organizations will be tested on monkeys as part of the [...]

S. Korean Company to Start Clinical Trial for Potential Coronavirus Treatment in U.S.

S. Korean Company to Start Clinical Trial for Potential Coronavirus Treatment in U.S.

SEOUL, June 11 (Korea Bizwire) — South Korean biopharmaceutical maker Genexine Inc. said Thursday it has won approval to conduct a clinical trial for its potential coronavirus treatment in the United States. The U.S. Food and Drug Administration (FDA) gave the green light for the phase 1 clinical trial of anti-cancer drug candidate GX-I7 for [...]

Korean Researcher Develops Breakthrough Parkinson’s Treatment

Korean Researcher Develops Breakthrough Parkinson’s Treatment

SEOUL, June 3 (Korea Bizwire) — A Korean scientist has succeeded in curing Parkinson’s disease using a patient’s own stem cells for the first time in history. Prof. Kim Kwang-soo of McLean Hospital, Harvard Medical School and his research team announced Tuesday that they had succeeded in a clinical treatment of transplanting stem cells extracted [...]

Celltrion’s COVID-19 Treatment Candidate Shows Positive Results in Animal Testing

Celltrion’s COVID-19 Treatment Candidate Shows Positive Results in Animal Testing

SEOUL, June 1 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc. announced Monday that positive results were shown for its treatment for the novel coronavirus in animal testing. The company said its antiviral antibody treatment showed a 100-fold reduction in the viral load of SARS-CoV-2, the virus known to be causing COVID-19, in an [...]

Khondrion Highlights Potential Role of Inflammatory Lipid Modulator Prostaglandin E2 in COVID-19 Disease and Proposes Potential Treatment Pathway with Sonlicromanol

Khondrion Highlights Potential Role of Inflammatory Lipid Modulator Prostaglandin E2 in COVID-19 Disease and Proposes Potential Treatment Pathway with Sonlicromanol

NIJMEGEN, the Netherlands, April 15 (Korea Bizwire) – Khondrion, a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial disease, has published a scientific hypothesis that the inflammatory lipid modulator, prostaglandin E2 (PGE2), may execute a prominent role in COVID-19 pathophysiology and proposes that its lead drug candidate, sonlicromanol, currently in phase IIb development to [...]

Samsung BioLogics Inks Manufacturing Deal for Coronavirus Treatment

Samsung BioLogics Inks Manufacturing Deal for Coronavirus Treatment

SEOUL, April 10 (Korea Bizwire) — Samsung BioLogics, a biopharmaceutical unit of South Korea’s Samsung Group, said Friday that it has clinched a US$362 million deal to manufacture a candidate treatment for the novel coronavirus. Under the deal, Samsung BioLogics will start full-scale production of U.S. drug firm Vir Biotechnology’s candidate COVID-19 treatment that is [...]